These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction. Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD; J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129 [TBL] [Abstract][Full Text] [Related]
12. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology. Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420 [TBL] [Abstract][Full Text] [Related]
13. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Capomolla S; Febo O; Gnemmi M; Riccardi G; Opasich C; Caporotondi A; Mortara A; Pinna GD; Cobelli F Am Heart J; 2000 Apr; 139(4):596-608. PubMed ID: 10740140 [TBL] [Abstract][Full Text] [Related]
14. Implications of Heart Rate in Patients with Left Ventricular Assist Devices. Imamura T; Kinugawa K; Narang N; Nishida H; Pinney S; Jeevanandam V; Ota T Int Heart J; 2022; 63(1):56-61. PubMed ID: 35095077 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and characteristics of patients with clinical improvement but not significant left ventricular reverse remodeling after cardiac resynchronization therapy. Auger D; van Bommel RJ; Bertini M; Delgado V; Ng AC; Ewe SH; Shanks M; Marsan NA; Mooyaart EA; Witkowski T; Poldermans D; Schalij MJ; Bax JJ Am Heart J; 2010 Oct; 160(4):737-43. PubMed ID: 20934569 [TBL] [Abstract][Full Text] [Related]
16. How to consider target heart rate in patients with systolic heart failure. Izumida T; Imamura T; Nakamura M; Fukuda N; Kinugawa K ESC Heart Fail; 2020 Oct; 7(5):3231-3234. PubMed ID: 32592292 [TBL] [Abstract][Full Text] [Related]
17. Chronic therapy with a partial adenosine A1-receptor agonist improves left ventricular function and remodeling in dogs with advanced heart failure. Sabbah HN; Gupta RC; Kohli S; Wang M; Rastogi S; Zhang K; Zimmermann K; Diedrichs N; Albrecht-Küpper BE Circ Heart Fail; 2013 May; 6(3):563-71. PubMed ID: 23564604 [TBL] [Abstract][Full Text] [Related]
18. Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE). St John Sutton M; Cerkvenik J; Borlaug BA; Daubert C; Gold MR; Ghio S; Chirinos JA; Linde C; Ky B J Am Heart Assoc; 2015 Sep; 4(9):e002054. PubMed ID: 26363005 [TBL] [Abstract][Full Text] [Related]
19. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD; J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245 [TBL] [Abstract][Full Text] [Related]
20. Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial. Colucci WS; Kolias TJ; Adams KF; Armstrong WF; Ghali JK; Gottlieb SS; Greenberg B; Klibaner MI; Kukin ML; Sugg JE; Circulation; 2007 Jul; 116(1):49-56. PubMed ID: 17576868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]